Xillix Technologies Corp. (TSX:XLX), the world leader in fluorescence endoscopy for the early detection of cancer, today announced an amendment (the “Amendment”) to its loan agreement (the “Loan Agreement”) dated December 20, 2005 with Hercules Technology Growth Capital, Inc. (the “Lender”).
